Clinical Trial: A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) Exhibiting Significant Deterioration While Taking Zidovudine (Retrovir)

Brief Summary: The objective of this open-label study regimen is to make didanosine (ddI) available to patients with AIDS who are clinically deteriorating on zidovudine (AZT) and cannot enter the Phase II ddI programs due to protocol exclusion or geographic location.

Detailed Summary:
Sponsor: Bristol-Myers Squibb

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Bristol-Myers Squibb

Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: October 1, 2007
Last Verified: October 2007